This year’s virtual event features experts from medical device companies, hospitals and government organizations.
Simplifying the PMS process globally from end to end, can help medtech companies realize significant improvements across the board while keeping operating costs under control.
The continued threat and spread of COVID-19 across the globe has led to seismic uncertainty for every industry.
Artificial intelligence and machine learning are proving to be meaningful weapons in our arsenal during the coronavirus crisis.
Whatever the short- and longer-term fallout of COVID-19, organizations will need to come back fighting—with new tools at their disposal and ready to raise their game.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
For too long this industry has lagged the pharma sector in terms of using data analytics to predict market trends. It’s time to change that.
Industry experts share advice that could influence company success.
Getting through the complex maze of regulatory requirements can be an overwhelming process for any medical device company.
The expanding international market poses a variety of challenges for medtech companies entering new global territories.